ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Secoisolariciresinol diglucoside-derived metabolite, enterolactone, attenuates atopic dermatitis by suppressing Th2 immune response

Yu, Lu; Xu, Qishan; Wang, Ping; Luo, Jialiang; Zheng, Zhuojun; Zhou, Jia; Zhang, Liyun; Sun, Ledong*; Zuo, Daming*南方医科大学; 5
International Immunopharmacology2022-10DOI: 10.1016/j.intimp.2022.109039
3被引9阅读
引用收藏
分享

摘要

Atopic dermatitis (AD) is a severe inflammatory skin disease caused by a combination of genetic, immune, and environmental factors. Intestinal microbiome disorders and changes in the immune microenvironment are associated with AD. We observed that gut bacterial metabolite enterolactone (ENL) was significantly reduced in AD model mice. Notably, patients with early childhood-onset AD exhibited decreased sera ENL level compared to the healthy controls, and the ENL level was negatively correlated with the SCORAD index. Secoisolariciresinol-diglycoside (SDG) is a natural dietary lignan of flaxseeds that can be converted by intestinal bacteria to ENL. Repeated applications of 2,4-dinitrochlorobenzene (DNCB) were performed on the ear and dorsal skin of mice to induce AD-like symptoms and skin lesions. Oral administration of SDG significantly decreased serum IgE levels and limited skin inflammation in the DNCB-induced AD mice. In addition, SDG treatment strongly limited the Th2 responses in AD mice. Moreover, we demonstrated that the IL-4 production was significantly suppressed by ENL under Th2 polarization conditions via the JAK-STAT6 signaling pathway in a concentration-dependent manner. We concluded that SDG and its derived metabolite ENL ameliorated AD development by reducing the Th2 immune response. These results suggested that SDG and ENL might be exploited as potential therapeutic candidates for AD treatment.

学科与关键词

关键词
Atopic dermatitisEnterolactoneSecoisolariciresinol-diglycosideTh2 cellsSTAT6
相关
加载中…
  • The protective effects of human milk components, 2′-fucosyllactose and osteopontin, against 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice
    Chen, Xi; Yang, Chunyan; Zeng, Jiaqi; Zhu, Zhengyumeng; Zhang, Liyun; Lane, Jonathan A.; Wu, Xueling; Zuo, Daming*Journal of Functional Foods, 2021, 87: 104806.被引 2
  • Inhibitory effects of isoliquiritin on an atopic dermatitis model through the CD177/JAK2/STAT pathway in vitro and in vivo
    Wu, Qing; Mo, Xiumei; Lin, Ying; Liu, Junfeng; Ye, Siqi; Zhang, Yu; Fan, Xingxing; Chen, Dacan*; Yan, Fenggen*Annals of Translational Medicine, 2022, 10(18).被引 1
  • Inhibitory effects of catalpol on DNCB-induced atopic dermatitis and IgE-mediated mast cells reaction
    Sun, Yun; Zhu, Defen; Qu, Lu; Li, Manping; Du, Wenxia; Wang, Mingming; Zhang, Yi; Chen, Guifang; Rao, Gaoxiong; Yu, Xiaoling; Wu, Xiangnong; Huang, Feng*; Tong, Xiaoyun*International Immunopharmacology, 2024, 126: 111274.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2022-10
卷期
第 111 卷
页码
109039
DOI
10.1016/j.intimp.2022.109039
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82071781]; Science and Technology Projects in Guangzhou [202002030160]; Administration of Traditional Chinese Medicine of Guangdong Province in China [20131161]; Discipline Development Foundation of the Fifth Affiliated Hospital of Southern Medical University; China Medicine Education Association

作者

  • Y

    Yu, Lu (第一作者)

    southern med univ

  • X

    Xu, Qishan

    southern med univ

查看全部 9 位作者收起作者
  • W

    Wang, Ping

    southern med univ

  • L

    Luo, Jialiang

    southern med univ

  • Z

    Zheng, Zhuojun

    southern med univ

  • Z

    Zhou, Jia

    southern med univ

  • Z

    Zhang, Liyun

    southern med univ

  • S

    Sun, Ledong (通讯)

    5 · southern med univ

  • Z

    Zuo, Daming (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417